| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
International Stem Cell Corp (ISCO) has 0 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. ISCO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2016 | Semechkin Andrey | Chief Executive Officer | Buy | 215,000 | $1.75 | $376,250.00 | +33.0% | |
| Mar 31, 2015 | Semechkin Ruslan | Chief Scientific Officer | Buy | 1,861,331 | $0.04 | $83,387.63 | +24.7% | |
| Mar 31, 2015 | Semechkin Andrey | Chief Executive Officer | Buy | 5,894,214 | $0.04 | $264,060.79 | +10.9% | |
| Feb 23, 2015 | Semechkin Ruslan | Chief Scientific Officer | Buy | 1,861,331 | $0.04 | $83,387.63 | +32.8% |